University of Technology Sydney, Sydney, NSW.
Independent Hospital Pricing Authority, Sydney, NSW.
Med J Aust. 2023 Apr 17;218(7):315-319. doi: 10.5694/mja2.51894. Epub 2023 Mar 22.
To examine out-of-pocket costs incurred by patients for radiation oncology services and their variation by geographic location.
Analysis of patient-level Medical Benefits Schedule (MBS) claims data linked with data from the Sax Institute 45 and Up Study.
SETTING, PARTICIPANTS: People who received Medicare-subsidised radiation oncology services in New South Wales, 2006-2017.
Mean out-of-pocket costs for an episode of radiation oncology (during 90 days from start of radiotherapy planning service), by geographic location (postcode-based), overall and after excluding episodes with no out-of-pocket costs (fully bulk-billed).
During 2006-2017, 12 724 people received 15 506 episodes of radiation oncology care in 25 postcode-defined geographic areas. The proportion of episodes for which the out-of-pocket cost was less than $1 increased from 39% in 2006 to 76% in 2017; the proportion for which out-of-pocket costs exceeded $500 declined from 43% in 2006 to 10% in 2014, before increasing to 17% in 2017. For care episodes with non-zero out-of-pocket costs, the mean amount rose from around $1186 to $1611 per episode of care during 2006-2017. The proportion of radiation oncology episodes bulk-billed exceeded 90% in nine areas; in seven areas, all with exclusively private care provision of radiation oncology, it was 21% or smaller. Within geographic areas, out-of-pocket costs for individual care episodes varied widely; in ten areas with lower bulk-billing rates, the interquartile range for costs ranged from $240 to $1857.
Out-of-pocket costs are an important determinant of access to care. Although radiotherapy costs for most people are moderate, some face very high costs, and these vary markedly by location. It is important to ensure that radiation oncology services remain affordable for all people who need treatment.
考察患者在放射肿瘤学服务方面的自付费用及其随地理位置的变化情况。
对与 Sax 研究所 45 岁及以上研究数据相关联的患者层面的医疗福利计划(MBS)索赔数据进行分析。
地点、参与者:2006 年至 2017 年期间在新南威尔士州接受医疗保险补贴放射肿瘤学服务的人。
按地理位置(邮政编码)划分的放射肿瘤学治疗(从放射治疗计划服务开始后 90 天内)每例治疗的平均自付费用,整体以及在排除无自付费用(全额批量计费)的病例后。
2006 年至 2017 年期间,有 12724 人在 25 个邮政编码定义的地理区域内接受了 15506 次放射肿瘤学治疗。自付费用低于 1 美元的病例比例从 2006 年的 39%增加到 2017 年的 76%;自付费用超过 500 美元的病例比例从 2006 年的 43%下降到 2014 年的 10%,然后在 2017 年上升到 17%。对于有非零自付费用的治疗病例,每个治疗病例的平均费用从 2006 年至 2017 年期间的 1186 美元左右上升到 1611 美元。九个地区的放射肿瘤学治疗全额批量计费比例超过 90%;在七个完全提供私人放射肿瘤学治疗的地区,这一比例为 21%或更低。在地理区域内,个别治疗病例的自付费用差异很大;在十个批量计费率较低的地区,费用的四分位距范围从 240 美元到 1857 美元不等。
自付费用是获得治疗的一个重要决定因素。尽管大多数人接受放射治疗的费用适中,但有些人的费用却非常高,而且这些费用因地点而异。确保所有需要治疗的人都能负担得起放射肿瘤学服务非常重要。